eglumetad has been researched along with Psychotic Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bures, MG; Carter, JH; Catlow, JT; Getman, BG; Hao, J; Heinz, BA; Henry, SS; Herin, M; Johnson, BG; Massey, SM; McKinzie, DL; Monn, JA; Reinhard, MR; Stephenson, GA; Swanson, S; Valli, MJ; Wang, X | 1 |
| Gourdon, JC; Huot, P; Maddaford, S; Nuara, SG | 1 |
2 other study(ies) available for eglumetad and Psychotic Disorders
| Article | Year |
|---|---|
Synthesis and pharmacological characterization of 4-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates: identification of new potent and selective metabotropic glutamate 2/3 receptor agonists.
Topics: Administration, Oral; Amino Acids, Dicarboxylic; Animals; Antipsychotic Agents; Bridged Bicyclo Compounds; Cyclohexanes; Humans; Male; Models, Molecular; Motor Activity; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Stereoisomerism; Structure-Activity Relationship | 2013 |
Additive effects of mGluR
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Bridged Bicyclo Compounds; Callithrix; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Male; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Pyridines; Receptors, Metabotropic Glutamate; Serotonin 5-HT2 Receptor Antagonists; Sulfonamides | 2021 |